PHARMACY

FDA approves Lupin’s generic Adcirca

BY Sandra Levy

Lupin has received the Food and Drug Administration’s blessing for its generic Adcirca (tadalafil) tablets in 20-mg dosage strength.

The product is the generic of Eli Lilly’s branded product. It is indicated for the treatment of pulmonary arterial hypertension to improve exercise ability.

The product had a market value of roughly $474.3 million, according to December 2018 IQVIA data.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

What area is your company focused most on in 2019?
  • Add your answer